Pancreatic cancer—a tumor displaying a particularly abundant stromal reaction—is
notorious for its poor prognosis. Recent studies, via newly developed orthotopic models …

Abstract Background/Aims: Due to enhanced imaging modalities, pancreatic cysts are being
increasingly detected, often as an incidental finding. They comprise a wide range of differing …

Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis due to the lack
of methods or biomarkers for early diagnosis and its resistance to conventional treatment …

Objective: To explore the role of pancreatic ductal adenocarcinoma (PDAC) size on surgical
and survival outcomes. Background: Tumor size is a prognostic factor for the majority of solid …

To review literature addressing determination of the risk factor, early diagnosis and overall
survival on outcome among patient of pancreatic cancer associated with diabetes mellitus …

Background Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis. There is
a need to identify prognostic subtypes of PDAC to predict clinical and therapeutic outcomes …

Objective This study aimed to assess the feasibility, safety, and efficacy of radiofrequency
ablation (RFA) of pancreatic neuroendocrine tumors (PNETs). Methods We performed RFA …

Background One–fifth of patients with seemingly 'curable'pancreatic ductal adenocarcinoma
(PDA) experience an early recurrence and death, receiving no definable benefit from a …

Recent studies describe a heterogeneous population of cells of the myeloid lineage, termed
myeloid derived suppressor cells (MDSC), which are observed with increased prevalence in …

BACKGROUND Pancreatic ductal adenocarcinoma is the most common pancreatic cancer.
Five-year overall survival is currently 3.3–6.0%. The aim of this review was to evaluate the …